多西他赛每周疗法联合精确放疗治疗老年晚期非小细胞肺癌疗效观察(2)
 |
| 第1页 |
参见附件(1397KB，2页)。
参 考 文 献
[1] YANCIK R.Cancer burden in the aged.An ep idemiologic and demographic overviem.Cancer,1997,80(7):1273-1283.
[2] LEE-CH IONG J T,MATTHAY R A.Lung cancer in the elderly patient.Clin ChestMed,1993,14(3):453-478.
[3] 吴德华,陈龙华. 非小细胞肺癌三维适形放疗疗效观察.中华放射肿瘤学杂志,2003,12(4):220-222.
[4] Graham MV,Purdy JA,Emami B,et al.Clinical dose-volume histogram analysis for pneumonitis after 3-D treatment for non-small cell lung cancer.Int J Radiat Oncol Biol phys,1999,45(2):323-329.
[5] Sunyach MP, Falchero L, Pommier P,et al. Prospective evaluation of early lung toxicity following three-lung cancer:preliminary results.Int J Radiat Oncol Biol Phys,2002,48(2):459-463.
[6] 廖美琳.肺癌现代治疗学.上海医科大学出版社,1998,259.
[7] Georgoulias V,Ardavanis A,Agelidou A,et al.Docetaxel versus docetacel plus cisplatin as front-line treatment of patients with advanced non-small lung cancer:a randomized,multicenter phase III trial.J Clin Oncol,2004,22(13):2602-2609.
[8] 张彤,任国平,张振海.单药泰索帝每周方案治疗晚期老年人非小细胞肺癌64例疗效观察.现代肿瘤医学,2006,14(12):1540-1542.
[9] RoszkowskiK,Pluzanska A,Krzakowski M,et al.Amulticenter,randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer.Lung Cancer,2000,27(3):145-157.
[10] 韩兴华,陈振东.老年癌症患者的化疗耐受性与安全性分析.现代肿瘤医学,2008,16(3):465-467.
[11] 周彩存,郑迪,张捷,等. 多西紫杉醇联合顺铂一线治疗晚期非小细胞肺癌.临床肿瘤学杂志,2004,9(1):8-1.
您现在查看是摘要介绍页，详见PDF附件(1397KB，2页)。